Alternative Treatments Of Dementia And Mild Cognitive Impairment

This book is offered as a practical resource on safe, effective and affordable alternative treatments of dementia and mild cognitive impairment (MCI). If you or a loved one are struggling with Alzheimer’s disease (or another type of dementia) or mild cognitive impairment (MCI) this book provides valuable information about non-medication alternatives including lifestyle changes such as exercise and nutrition, herbals and other natural supplements, meditation and mind-body practices and many others. This book is written to give you the maximum amount of information in the least amount of time. From the contents you can instantly navigate to sections that will help you: • Understand dementia better • Take inventory of your symptoms • Identify treatments that make sense for you based on the research evidence • Learn about alternative treatments of dementia and mild cognitive impairment • Develop a customized treatment plan that is right for you • Re-evaluate your treatment plan and make changes if your initial plan doesn’t work If you are a mental health professional this book provides concise, jargon-free summaries of alternative treatments of dementia and mild cognitive impairment. An appendix with links to valuable internet resources is included to help you find quality brands of natural supplements and important safety information. This book is part of a series on alternative and integrative treatments of mental health problems. Other books in the series cover: · Alcohol and drug abuse · Anxiety · Attention Deficit Hyperactivity Disorder (ADHD) · Bipolar disorder · Depression · Insomnia · Post-traumatic stress disorder (PTSD) · Schizophrenia

This book is offered as a practical resource on safe, effective and affordable alternative treatments of dementia and mild cognitive impairment (MCI). If you--or someone you are caring for--are struggling with mild cognitive impairment, Alzheimer's disease or another form of dementia, and you are taking a medication that isn't helping, experiencing adverse effects, or you simply can't afford to continue taking a medication that is working this book provides valuable information about non-medication alternatives that will help lessen the severity of your cognitive problems using herbals and other natural supplements, meditation and mind-body practices, and energy therapies. This book is written to give you the maximum amount of information in the least amount of time. From the contents you can instantly navigate to sections that will help you:*Understand dementia and mild cognitive impairment (MCI) better*Take inventory of your symptoms*Identify treatments that make sense for you based on the research evidence*Learn about alternative treatments of MCI and dementia *Develop a customized treatment plan that is right for you*Re-evaluate your treatment plan and make changes if your initial plan doesn't workIf you are a mental health professional this book provides concise, jargon-free summaries of non-medication treatments you can use when advising clients about safe, effective treatments of MCI and dementia.An appendix with links to valuable internet resources is included to help you find quality brands of natural supplements and important safety information. This book is part of a series on alternative treatments of mental health problems. Other books in the series cover: *Alcohol and drug abuse*Anxiety*Attention-deficit hyperactivity disorder (ADHD)*Bipolar disorder*Depression*Insomnia *Post-traumatic stress disorder (PTSD)*Schizophrenia

As the largest generation in U.S. history - the population born in the two decades immediately following World War II - enters the age of risk for cognitive impairment, growing numbers of people will experience dementia (including Alzheimer's disease and related dementias). By one estimate, nearly 14 million people in the United States will be living with dementia by 2060. Like other hardships, the experience of living with dementia can bring unexpected moments of intimacy, growth, and compassion, but these diseases also affect people's capacity to work and carry out other activities and alter their relationships with loved ones, friends, and coworkers. Those who live with and care for individuals experiencing these diseases face challenges that include physical and emotional stress, difficult changes and losses in their relationships with life partners, loss of income, and interrupted connections to other activities and friends. From a societal perspective, these diseases place substantial demands on communities and on the institutions and government entities that support people living with dementia and their families, including the health care system, the providers of direct care, and others. Nevertheless, research in the social and behavioral sciences points to possibilities for preventing or slowing the development of dementia and for substantially reducing its social and economic impacts. At the request of the National Institute on Aging of the U.S. Department of Health and Human Services, Reducing the Impact of Dementia in America assesses the contributions of research in the social and behavioral sciences and identifies a research agenda for the coming decade. This report offers a blueprint for the next decade of behavioral and social science research to reduce the negative impact of dementia for America's diverse population. Reducing the Impact of Dementia in America calls for research that addresses the causes and solutions for disparities in both developing dementia and receiving adequate treatment and support. It calls for research that sets goals meaningful not just for scientists but for people living with dementia and those who support them as well. By 2030, an estimated 8.5 million Americans will have Alzheimer's disease and many more will have other forms of dementia. Through identifying priorities social and behavioral science research and recommending ways in which they can be pursued in a coordinated fashion, Reducing the Impact of Dementia in America will help produce research that improves the lives of all those affected by dementia.

In 2011, National Institute on Aging and Alzheimer's Association joint task forces released proposed criteria for Alzheimer' disease diagnosis. These proposals included revisions to the nearly 30-year-old NINDS-ADRDA criteria for Alzheimer's diagnosis and added criteria for diagnosis of Mild Cognitive Impairment (MCI) due to Alzheimer's disease. The same year the American Psychiatric Association proposed new criteria for major and minor neurocognitive disorders (the entities previously known as dementia and mild cognitive impairment, respectively). These new criteria reflect the research and clinical advances in identifying mild cognitive impairment and offer new opportunities for prevention, treatment, and management of neurodegenerative conditions. A major focus of this book is on the mild cognitive impairment prodrome of the common dementias. In addition to discussing the most common neurodegenerative conditions, many rare neurodegenerative conditions are highlighted. Most chapters include an autopsy-confirmed case presentation from the authors' files. Following the case presentation, those chapters present current diagnostic criteria, epidemiology, neuropathology/neurophysiology, genetics, neuroimaging studies as relevant, associated clinical features, differential neuropsychological features and possible interventions for each disorder. The pace of change in research and practice in the field of normal cognitive aging and dementia is increasing almost as fast as the median age of the population. The massive baby boom population bubble is currently entering the age of risk for neurodegenerative conditions. Neuropsychologists will play a major role in refining and applying these diagnoses, and in developing, testing, and refining interventions for these diagnoses, and in caring for this population. This book is intended to prepare neuropsychologists and others interested in neuropsychology to serve this fastest growing segment of our population.

Alzheimer's Disease was a finalist for a 2005 ForeWord Book of the Year Award! An estimated 5 million Americans suffer from Alzheimer's disease, only half of whom have been diagnosed. An uncertain but even larger number have mild cognitive impairment, often a precursor to Alzheimer's. By 2030, barring a cure for this illness, the number of individuals diagnosed with Alzheimer's disease is estimated to be 8 million, and by 2050, 14 million. The cost in both suffering and dollars on the part of patients and families is enormous and continues to grow worldwide. Alzheimer's Disease provides an overview of the latest findings regarding the cause, diagnosis, and treatment of Alzheimer's disease. It will help caregivers and family members gain a better understanding of the nature of the disease process and the available options for coping with and managing this illness. Chapters include an introduction to dementia and Alzheimer's disease, aging; memory; depression; medications; alternative treatments; stages and prognosis of the disease; a chapter for caregivers; and much more. The subtitles of each chapter are written in question format to help readers search for the topics that most relate to their problem. To further help navigate this book, references are organized by topic and chapter at the end of the book. In addition, all abbreviations are listed in a table at the beginning of the book, and words that appear in the glossary are italicized upon their first occurrence in the text. This latest volume in the American Academy of Neurology Press Quality of Life Guide series is an essential tool for all families coping with Alzheimer's disease.

This book is for individuals with mild cognitive impairment (MCI), their loved ones, and health care professionals who care for these patients. The text is loaded with up-to-date, scientifically substantiated knowledge about what MCI is, how it affects people, and how to take a proactive approach to health and wellbeing for living with MCI.

A deadly neurological malady characterized by progressive and irreparable shrinking of brain tissue, Alzheimer’s disease causes declines in memory, social abilities, and communication skills that accelerate aging and eventually lead to death. Conventional medicine has failed to develop treatments for this terrifying disease. No drug or proprietary medicine has been shown to be effective. In this groundbreaking book, leading integrative psychiatrist Dr. James M. Greenblatt reveals that hope has come from new research showing the answer lies with an integrative approach, of which nutrition is a key factor. The key lies in low-dose nutritional lithium, a naturally occurring mineral with a long and well-documented history of restoring brain and nervous system function at the molecular level. Integrative Medicine for Alzheimer’s presents this simple and effective approach to the prevention and treatment of dementia, delivering a wealth of scientific support for the clinical use of nutritional lithium, including: ■ Insight into the causes of Alzheimer’s disease ■ New information about nutritional lithium and its clinical use in the prevention Alzheimer’s disease ■ Research showing how antioxidants and anti-inflammatory nutrients support brain health ■ A roadmap for you and your doctor to build an integrative treatment plan to preserve healthy brain function

Mild Cognitive Impairment (MCI) has been identified as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). Since treatments for AD are most likely to be most effective early in the course of the disease, MCI has become a topic of great importance and has been investigated in different populations of interest in many countries. This book brings together these differing perspectives on MCI for the first time. This volume provides a comprehensive resource for clinicians, researchers, and students involved in the study, diagnosis, treatment, and rehabilitation of people with MCI. Clinical investigators initially defined mild cognitive impairment (MCI) as a transitional condition between normal aging and the early stages of Alzheimer’s disease (AD). Because the prevalence of AD increases with age and very large numbers of older adults are affected worldwide, these clinicians saw a pressing need to identify AD as early as possible. It is at this very early stage in the disease course that treatments to slow the progress and control symptoms are likely to be most effective. Since the first introduction of MCI, research interest has grown exponentially, and the utility of the concept has been investigated from a variety of perspectives in different populations of interest (e.g., clinical samples, volunteers, population-based screening) in many different countries. Much variability in findings has resulted. Although it has been acknowledged that the differences observed between samples may be ‘legitimate variations’, there has been no attempt to understand what it is we have learned about MCI (i.e., common features and differences) from each of these perspectives. This book brings together information about MCI in different populations from around the world. Mild Cognitive Impairment will be an important resource for any clinician, researcher, or student involved in the study, detection, treatment, and rehabilitation of people with MCI.